ABC00077LY

Mirabegron EP impurity G

Mirabegron EP impurity G is a structurally related degradation byproduct arising from oxidative cleavage of the benzimidazole core in Mirabegron, resulting in a truncated aromatic ring system with a terminal carboxylic acid functionality. This impurity retains the piperidine-based side chain but exhibits a loss of the methoxy substituent at the 5-position of the benzene ring, replaced by a hydroxyl group conjugated to a dicarboxylic acid moiety. The compound serves as a critical HPLC reference standard for quantifying degradation pathways in stability-indicating assays of Mirabegron formulations.

On Request
Molecular Formula N/A
Molecular Weight N/A
CAS Number N/A
PubChem CID N/A
Purity 95%
Product Type API Impurity
Parent Drug Mirabegron
Lead Time 14 Days
IUPAC Name ?(R)-2-(2-Aminothiazol-5-yl)-N-(4-(2-((4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)amino)-2-oxoethyl)thiazol-2-yl)acetamide

๐Ÿ”ฌ Chemical Identifiers

NC=1SC(=CN1)CC(=O)NC=1SC=C(N1)CC(=O)NC1=CC=C(C=C1)CCNC[C@@H](C1=CC=CC=C1)O
InChI=1S/C26H28N6O3S2/c27-25-29-14-21(37-25)13-24(35)32-26-31-20(16-36-26)12-23(34)30-19-8-6-17(7-9-19)10-11-28-15-22(33)18-4-2-1-3-5-18/h1-9,14,16,22,28,33H,10-13,15H2,(H2,27,29)(H,30,34)(H,31,32,35)/t22-/m0/s1
RMCCYYJIMVJWKR-QFIPXVFZSA-N

Related Products